Kakkis Emil D

Avg. Two Year Performance

15% Avg. Purchase Return
7% Compound
11% Avg. Sale Return
5% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return< 1%(7%)(9%)49%15%
Purchase Success Rate2 of 30 of 31 of 32 of 32 of 3
Average Sale Return< 1%7%12%15%11%
Sale Success Rate10 of 2717 of 2719 of 2717 of 2715 of 27
Drugs » Biotechnology

President & CEO, Director:

Holdings: 2.79M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

Chief Medical Officer:

Holdings: 44.27K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--